Recent Insider Activity Suggests Potential Gains for Akebia Therapeutics Inc. (AKBA)

Akebia Therapeutics Inc.’s recently made public that its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0 on Feb 29 ’24. In the deal valued at $1.58 per share,46,570 shares were sold. As a result of this transaction, Butler John P. now holds 2,044,580 shares worth roughly $4.44 million. Then, Dahan Michel […]

AKBA Stock Sees Decline of Approximately -5.37% in Last Five Days

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Akebia Therapeutics Inc. shares valued at $73,581 were sold by Butler John P. on Feb 29 ’24. At $1.58 per share, Butler John P. sold 46,570 shares. The insider’s holdings dropped […]

A Guide To The Risks Of Investing In Akebia Therapeutics Inc. (AKBA)

Akebia Therapeutics Inc.’s recently made public that its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0 on Feb 29 ’24. In the deal valued at $1.58 per share,46,570 shares were sold. As a result of this transaction, Butler John P. now holds 2,044,580 shares worth roughly $3.01 million. Then, Dahan Michel […]

AKBA Shares Experience Decline in Value

The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Akebia Therapeutics Inc. shares valued at $73,581 were sold by Butler John P. on Feb 29 ’24. At $1.58 per share, Butler John P. sold 46,570 shares. The insider’s holdings dropped […]

The Attractiveness of Investing In Akebia Therapeutics Inc. (AKBA) is Growing

Akebia Therapeutics Inc.’s filing revealed that its CEO and President Butler John P. unloaded Company’s shares for reported $73581.0 on Feb 29. In the deal valued at $1.58 per share,46,570 shares were sold. As a result of this transaction, Butler John P. now holds 2,044,580 shares worth roughly $3.5 million. Then, Dahan Michel sold 8,661 […]

Akebia Therapeutics Inc. [AKBA] Records 50-Day SMA of $1.4618

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Akebia Therapeutics Inc. shares valued at $78,102 were sold by Butler John P. on Feb 01. At $1.68 per share, Butler John P. sold 46,489 shares. The insider’s holdings dropped to 2,128,883 shares worth […]

BTIG Research gives a Buy recommendation for Akebia Therapeutics Inc. (AKBA)

In a filing, Akebia Therapeutics Inc. revealed its CEO and President Butler John P. unloaded Company’s shares for reported $78102.0 on Feb 01. In the deal valued at $1.68 per share,46,489 shares were sold. As a result of this transaction, Butler John P. now holds 2,128,883 shares worth roughly $2.87 million. Then, Burke Steven Keith […]

AKBA’s latest rating updates from top analysts.

Akebia Therapeutics Inc.’s filing revealed that its CEO and President Butler John P. unloaded Company’s shares for reported $78102.0 on Feb 01. In the deal valued at $1.68 per share,46,489 shares were sold. As a result of this transaction, Butler John P. now holds 2,128,883 shares worth roughly $3.07 million. Then, Burke Steven Keith sold […]

An Analysis of Akebia Therapeutics Inc. (AKBA)’s Potential Price Growth

Akebia Therapeutics Inc.’s recently made public that its CEO and President Butler John P. unloaded Company’s shares for reported $78102.0 on Feb 01. In the deal valued at $1.68 per share,46,489 shares were sold. As a result of this transaction, Butler John P. now holds 2,128,883 shares worth roughly $3.24 million. Then, Burke Steven Keith […]